Page last updated: 2024-11-13
phidianidine b
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
phidianidine B: antineoplastic from the marine opisthobranch mollusk Phidiana militaris; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 60150771 |
CHEMBL ID | 4291488 |
SCHEMBL ID | 15275388 |
MeSH ID | M0558906 |
Synonyms (7)
Synonym |
---|
SCHEMBL15275388 |
phidianidine b |
nsc-764070 |
nsc764070 |
1301638-42-5 |
CHEMBL4291488 |
HY-143242 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (4)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1419748 | Inhibition of mu opioid receptor (unknown origin) at 10 uM | 2017 | Journal of natural products, 11-22, Volume: 80, Issue:11 | Natural Products with Heteroatom-Rich Ring Systems. |
AID1419745 | Inhibition of dopamine transporter (unknown origin) at 10 uM | 2017 | Journal of natural products, 11-22, Volume: 80, Issue:11 | Natural Products with Heteroatom-Rich Ring Systems. |
AID1419746 | Inhibition of norepinephrine transporter (unknown origin) at 10 uM | 2017 | Journal of natural products, 11-22, Volume: 80, Issue:11 | Natural Products with Heteroatom-Rich Ring Systems. |
AID1419747 | Inhibition of serotonin transporter (unknown origin) at 10 uM | 2017 | Journal of natural products, 11-22, Volume: 80, Issue:11 | Natural Products with Heteroatom-Rich Ring Systems. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.31
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.31) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (25.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (75.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |